Provided by Tiger Fintech (Singapore) Pte. Ltd.

Halozyme Therapeutics

65.87
-1.8600-2.75%
Post-market: 66.500.6300+0.96%19:20 EDT
Volume:2.50M
Turnover:168.11M
Market Cap:8.12B
PE:17.52
High:69.94
Open:68.11
Low:65.68
Close:67.73
Loading ...
Mar 01, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 23, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 26, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2021

Major Issues Report

8-K - Current report
Jan 11, 2021

Major Issues Report

8-K - Current report
Dec 08, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2020

Major Issues Report

8-K - Current report
May 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2020

Major Issues Report

8-K - Current report
May 04, 2020

Major Issues Report

8-K - Current report
Apr 09, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals